Swiss Neonatal Network & Follow-up Group

Launched by SWISS NEONATAL NETWORK · Jan 20, 2020

Keywords

ClinConnect Summary

The Swiss Neonatal Network & Follow-Up Group (SwissNeoNet) is a clinical trial aimed at improving the care and safety of high-risk newborns in Switzerland. This study focuses on very low birth weight infants, very preterm infants, and those who have experienced a lack of oxygen at birth (known as asphyxia). The goal is to gather important information that will help healthcare providers deliver better medical care to these vulnerable babies and support their families.

To participate in this study, infants need to meet specific criteria. For example, eligible babies must be born alive in Switzerland and either weigh less than 1501 grams (about 3.3 pounds) or be born before 32 weeks of pregnancy. There are additional criteria for slightly older infants who may have experienced complications during birth. If families choose to participate, they can expect their infants to be part of a coordinated effort to collect important health data, which will help improve treatment and support for future generations of high-risk newborns. This trial is currently recruiting participants, and all genders are welcome.

Gender

ALL

Eligibility criteria

• Inclusion criteria of "Minimal Neonatal Dataset" (MNDS):
• • All Swiss live-born infants below 32 weeks gestational age or 1501g birth weight
• Inclusion criteria of "Below 34 data collection", (B34):
• • All Swiss live-born infants between 32 0/1 and 33 6/7 weeks gestational age that are above 1500g birth weight
• Inclusion criteria of "Swiss Asphyxia and Cooling Registry", (ASP):
• • Infants between 35 0/7 and 42 6/7 weeks' gestational age with moderate or severe encephalopathy due to perinatal asphyxia